Multiple sclerosis research

MS stem cell treatment and advances in research are giving new hope to people affected by Multiple Sclerosis. Swiss Medica is offering access to Multiple Sclerosis stem cell therapy. This Multiple Sclerosis Treatment are being studied for their efficacy in improving the complications in patients with MS, through the use of stem cells. These procedures may help patients who don’t respond to typical drug treatment, want to reduce their reliance on medication or are looking to try stem cell therapy before starting drug treatment.

Multiple sclerosis (MS) is widely believed to be an autoimmune condition – the body’s immune system mistakenly attacks, and subsequently damages, the ‘myelin sheath’ protecting nerve cells in the brain and spinal cord. This damage causes messages to and from the brain to be slowed, distorted or stopped altogether. This is what leads to the symptoms of MS.

This stem cell treatment is designed to target the myelin sheath by introducing adult mesenchymal stem cells past the blood brain barrier so they may differentiate into and repair the myelin sheath nerve cells. Multiple Sclerosis is an auto-immune condition, adipose derived mesenchymal stem cells have the ability to repair the immune system; keeping it from attacking itself.

		From	To	From	To	From	To
Monday	Open
Tuesday	Open
Wednesday	Open
Thursday	Open
Friday	Open
Saturday	Open
Sunday	Open